# Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease

> Research article (Alzheimer s & Dementia Translational Research & Clinical Interventions, 2016) · cited 87× · AI/ML

**Wikidata**: [openalex:W2275089335](https://www.wikidata.org/wiki/openalex:W2275089335)  
**Source**: https://4ort.xyz/entity/design-of-a-bayesian-adaptive-phase-2-proofofconcept-trial-for-ban2401-a-putative-diseasemodifying-monoclonal-antibody-f